Navigation Links
John Daly, Previous Merck Exec., Starts CTW Consulting Firm
Date:12/2/2013

NEW YORK, Dec. 2, 2013 /PRNewswire-iReach/ -- Former Merck executive, John Daly, recently founded CTW with two primary missions.

(Photo: http://photos.prnewswire.com/prnh/20131202/MN25895)

The first is to offer pharmaceutical industry consulting services to corporations such as IMS Health. Providing strategy for next-generation commercialization solutions focused on integrated and accountable care emerging stakeholders and next-generation sales excellence solutions for the new pharma environment.

In addition, CTW's front-line leadership and coaching mission is to ensure their clients identify and cultivate engaging leadership. Through customer centric coaching, CTW clients empower culture, fuel innovation and the full realization of their vision.

"A great business model, people, commercial opportunity and a defined vision is not enough. Investing in and putting your people first means having purposeful, strategic and effective front-line leaders." said Daly. CTW's Customer Centric Coaching model ingrains four core coaching principles that enable sales leaders to identify, leverage and build upon what motivates individual sales professionals.

Daly's previous employment as director of commercial operations and regional sales director at Schering Plough / Merck has allowed him to fuel hundreds of millions in sales by directing multiple regions and teams in brand sales to primary care, multispecialty, integrated physician groups, and managed care organizations. Daly has also strengthened and led innovative healthcare partnerships, solutions and quality outcome-focused strategies.

To learn more about John Daly and CTW visit http://john-daly-merck.com/

About John Daly

With two decades of experience in the pharmaceutical industry, John Daly has served as a sales leader and director of commercial operations since 2004 with Bayer Healthcare, Schering Plough Corporation and Merck & Co., Inc. based in North Wales, Pennsylvania. He has led the commercial operations of several regions in a number of therapeutic areas including respiratory allergy and asthma, diabetes, neurology and cardiovascular disease. His success has included developing current leaders, brand team partnerships and field leadership of multiple product launches and excellent integration and change leadership. Daly's consistent strong performance as a regional sales director has earned him a number of sales awards and corporate recognitions spanning cross-functional programs and special initiatives.

Media Contact: Deanna Dunsmuir, X Factor Selling Systems, 9736008321, deanna@thesalesexpertusa.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE CTW consulting
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gen-Probe Withdraws from Previously Announced Investor Presentations
2. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
3. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
4. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
5. PDI, Inc. Announces Client FDA Product Approval Related to Previously Disclosed Contract
6. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
7. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
8. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
9. Assisted Reproduction: New Technology Identifies Previously Unknown Predictors of Embryo Viability
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):